NCT05288452

Brief Summary

Brief Summary: The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
2mo left

Started Jan 2023

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2023Jun 2026

First Submitted

Initial submission to the registry

February 17, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 21, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

3.5 years

First QC Date

February 17, 2022

Last Update Submit

May 29, 2025

Conditions

Keywords

Diabetes Mellitus, Type 2HIV

Outcome Measures

Primary Outcomes (2)

  • FREEDOM Study: Change in HbA1c level between baseline and 12 month

    The primary outcome of the study is to track change in the HbA1c between baseline and 12 months (endpoint of the study). The HbA1C will be tested at baseline, 6 and 12 months.

    12 months

  • Primary Outcome for the HIV Cohort: Change in HbA1c level between baseline and 6 months

    The primary outcome of the study is to track change in the HbA1c between baseline and 6 months (endpoint of the study). The HbA1C will be tested at baseline and 6 months.

    6 months

Study Arms (8)

Arm 1

EXPERIMENTAL

Digital coaching+ Food delivery+ RPM

Behavioral: Digital Health CoachingDietary Supplement: Food Box DeliveryBehavioral: Remote Patient Monitoring (RPM)Behavioral: Diabetes Education Class

Arm 2

ACTIVE COMPARATOR

Digital coaching

Behavioral: Digital Health CoachingBehavioral: Diabetes Education Class

Arm 3

ACTIVE COMPARATOR

Digital coaching+ Food delivery

Behavioral: Digital Health CoachingDietary Supplement: Food Box DeliveryBehavioral: Diabetes Education Class

Arm 4

ACTIVE COMPARATOR

Digital coaching+ RPM

Behavioral: Digital Health CoachingBehavioral: Remote Patient Monitoring (RPM)Behavioral: Diabetes Education Class

Arm 5

ACTIVE COMPARATOR

Food delivery+ RPM

Dietary Supplement: Food Box DeliveryBehavioral: Remote Patient Monitoring (RPM)Behavioral: Diabetes Education Class

Arm 6

ACTIVE COMPARATOR

The participant's will not receive any Intervention

Behavioral: Diabetes Education Class

Arm 7

ACTIVE COMPARATOR

Food delivery

Dietary Supplement: Food Box DeliveryBehavioral: Diabetes Education Class

Arm 8

ACTIVE COMPARATOR

RPM

Behavioral: Remote Patient Monitoring (RPM)Behavioral: Diabetes Education Class

Interventions

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

Arm 1Arm 2Arm 3Arm 4
Food Box DeliveryDIETARY_SUPPLEMENT

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

Arm 1Arm 3Arm 5Arm 7

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

Arm 1Arm 4Arm 5Arm 8

The diabetes education class will be administered by a certified diabetes educator.

Arm 1Arm 2Arm 3Arm 4Arm 5Arm 6Arm 7Arm 8

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified as Black/African American
  • ICD diagnosis of T2DM
  • ≥18 years of age
  • Ongoing insulin treatment
  • HbA1c ≥8% within 6 weeks of study screening
  • has the ability to converse in and read English
  • must provide written informed consent prior to enrollment

You may not qualify if:

  • Current enrollment in any diabetes-related interventional study
  • Cognitive impairment
  • End-stage kidney disease (CKD-5)
  • Pregnant or plans to become pregnant within 12 months
  • Currently enrolled in a structured lifestyle change program
  • Enrolled in remote patient monitoring or health coaching within 60 days of the study or intervention
  • HIV Cohort Criteria
  • ≥ 18 years of age
  • ICD diagnosis of T2DM
  • HbA1c ≥ 7%
  • Confirmed HIV+ diagnosis
  • Prescribed HIV ART therapy as part of care
  • Current enrollment in any diabetes-related interventional study or structured lifestyle change program
  • Enrolled in RPM or health coaching (except for coaching on smoking cessation) within 60 days of the intervention
  • Cognitive impairment
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UAB Hospital and UMMC Cardiology Clinics

Birmingham, Alabama, 35205, United States

Location

Related Publications (1)

  • El Zein A, Garla V, Hall ME, Nawshin T, Hays D, John T, Delaney E, Wallace E, Hearld L, Cherrington AL, Mehta T. Rationale and design of the FREEDOM study: A hybrid type 1 optimization-implementation trial to improve type 2 diabetes management in primary care. Contemp Clin Trials. 2026 Feb;161:108173. doi: 10.1016/j.cct.2025.108173. Epub 2025 Dec 5.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Remote Patient Monitoring

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

TelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: We used the multiphase optimization strategy (MOST) as the ideal approach for the proposed study as, with the three proposed intervention components, identifying an optimal intervention through a single randomized controlled trial (RCT) with multiple arms or through multiple RCTs would be methodologically inefficient and resource-intensive. Given this, we rely on the eloquent and rigorous MOST-based optimization design, which leverages factorial experimentation to identify an optimal set of intervention component(s). In a factorial experiment, the goal is not to compare individual experimental conditions (in this case, eight conditions), but to use combinations of conditions to estimate the main and interaction effects of the intervention components. Thus, numerous intervention components can be evaluated simultaneously while utilizing the entire randomized sample.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Director of Research

Study Record Dates

First Submitted

February 17, 2022

First Posted

March 21, 2022

Study Start

January 1, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations